The observation that B7-1 is expressed on podocytes in DN and that CTLA4-Ig therapy reduces albuminuria in animal models for DN raised the possibility that abatacept could be used as a treatment for patients with DN [4]. The gene discussed is CD80; the disease is liver dysplastic nodule.